Receptos: Will Celgene Depose Biogen to Become Top Dog In Multiple Sclerosis?
While Celgene looks to move into the MS space, Biogen isn't going down without a fight
Read full article »
CEO
Receptos is focused on discovering, developing and commercializing therapeutics in immune disorders.
Read more